Holen Sie sich die Stockscreener-App
27.93
2.00%
-0.57
Schlusskurs vom Vortag:
$28.50
Offen:
$28.93
24-Stunden-Volumen:
2.67M
Relative Volume:
0.62
Marktkapitalisierung:
$4.98B
Einnahmen:
$644.86M
Nettoeinkommen (Verlust:
$196.05M
KGV:
28.47
EPS:
0.9812
Netto-Cashflow:
$317.50M
1W Leistung:
+6.00%
1M Leistung:
+6.12%
6M Leistung:
+22.66%
1J Leistung:
-61.20%
1-Tages-Spanne:
$27.80
$29.20
1-Wochen-Bereich:
$25.33
$29.20
52-Wochen-Spanne:
$17.15
$74.33
Doximity Inc Stock (DOCS) Company Profile
Firmenname
Doximity Inc
Sektor
Branche
Telefon
(650) 549-4330
Adresse
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, TEM, TXG, BTSG, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
27.93 | 4.70B | 644.86M | 196.05M | 317.50M | 0.9812 |
VEEV
Veeva Systems Inc
|
273.33 | 45.44B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
76.63 | 15.43B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
93.50 | 11.17B | 638.78M | -22.66M | 122.18M | -0.1744 |
BTSG
Brightspring Health Services Inc
|
60.25 | 11.20B | 13.65B | 169.86M | 412.12M | 1.0758 |
HNGE
Hinge Health Inc
|
97.67 | 7.71B | 646.34M | -512.40M | 202.76M | -6.6871 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-20 | Herabstufung | Truist | Buy → Hold |
| 2026-04-08 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2026-02-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2026-02-06 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2026-01-20 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-08 | Hochstufung | Truist | Hold → Buy |
| 2025-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-21 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-10-27 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-10-10 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-10-01 | Herabstufung | Goldman | Neutral → Sell |
| 2025-07-09 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-06-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-02-07 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Neutral |
| 2024-11-14 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Hochstufung | Needham | Hold → Buy |
| 2024-07-18 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-02 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-08-09 | Herabstufung | Needham | Buy → Hold |
| 2023-08-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Eingeleitet | Wells Fargo | Overweight |
| 2022-10-24 | Eingeleitet | Evercore ISI | In-line |
| 2022-10-13 | Eingeleitet | BTIG Research | Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Eingeleitet | Berenberg | Buy |
| 2022-05-18 | Bestätigt | BofA Securities | Neutral |
| 2022-05-18 | Bestätigt | Goldman | Buy |
| 2022-05-18 | Bestätigt | Guggenheim | Buy |
| 2022-05-18 | Bestätigt | Jefferies | Buy |
| 2022-05-18 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Bestätigt | Needham | Buy |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-04 | Eingeleitet | BofA Securities | Neutral |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-11-10 | Bestätigt | Canaccord Genuity | Buy |
| 2021-11-10 | Bestätigt | Goldman | Neutral |
| 2021-11-10 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Bestätigt | Needham | Buy |
| 2021-11-10 | Bestätigt | Piper Sandler | Overweight |
| 2021-08-26 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-19 | Eingeleitet | Goldman | Neutral |
| 2021-07-19 | Eingeleitet | JP Morgan | Overweight |
| 2021-07-19 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-19 | Eingeleitet | Raymond James | Outperform |
| 2021-07-19 | Eingeleitet | SVB Leerink | Outperform |
| 2021-07-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Doximity Inc Aktie (DOCS) Neueste Nachrichten
2,000 Doximity (DOCS) shares worth $57,820 are in director Kira Wampler's proposed sale. - Stock Titan
Telehealth sector outlook: Doximity, Hims & Hers, and Teladoc compared By Investing.com - Investing.com Canada
Doximity, Inc. (DOCS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Morningstar
Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
DOCS Deadline Alert: SueWallSt Reminds Doximity, Inc. (DOCS) Investors of Securities Class Action Deadline on November 16, 2026 - PR Newswire
Form 144 DOXIMITY For: 1 October By Investing.com - Investing.com Canada
רוזן, משרד עורכי דין מוביל, קורא למשקיעי חברת Doximity, Inc לשכור ייצוג משפטי לקראת מועד אחרון חשוב במסגרת תביעה ייצוגית בניירות הערך – DOCS - GlobeNewswire Inc.
Doximity, Inc. (DOCS) Stock Forecasts - Yahoo Finance
DOCS ALERT: Securities Fraud Class Action Launched Against Doximity, Inc. – November 16, 2026 Deadline - ACCESS Newswire
ROSEN, TOP-RANKED TRIAL ATTORNEYS, Encourages Doximity, - GlobeNewswire
UiPath, monday.com, Amplitude, Doximity, and Sprinklr Shares Skyrocket, What You Need To Know - Yahoo Finance
A Look at Doximity Inc (DOCS) After 6.9% Gain -- GF Value $45.85 vs Price $28.34 - GuruFocus
1,290 Doximity (DOCS) shares are proposed for sale by director Phoebe L. Yang Watkin. - Stock Titan
Doximity (NYSE:DOCS) Stock Jumps 6.9%What's Next? - MarketBeat
DOCS UPCOMING DEADLINE: Levi & Korsinsky Alerts Doximity, Inc. Stockholders of Securities Class ActionContact the Firm - PR Newswire
Doximity Jumps 5.7% Amid Sector-Wide Rally - AlphaStreet
DOXIMITY, INC. (DOCS) SHAREHOLDER ALERT Bernstein Liebhard - GlobeNewswire
Doximity Is Maintained at In-Line by Evercore ISI Group - Moomoo
Kaplan Fox Encourages Doximity, Inc. (NYSE: DOCS) Investors to Co - The National Law Review
Doximity (DOCS) Gains As Market Dips: What You Should Know - Yahoo Finance
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines – DOCS - FinancialContent
Shareholders who lost money in shares of acquired Doximity, - GlobeNewswire
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
Contact Levi & Korsinsky by November 16, 2026 to Join Class Action Against Doximity, Inc. (DOCS) - ACCESS Newswire
Form 4 Doximity Inc For: 28 September By Investing.com - Investing.com Australia
INVESTOR DEADLINE: Doximity, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit before November 16, 2026 Deadline, Robbins Geller Rudman & Dowd LLP AnnouncesDOCS - Business Wire
Deadline Approaching: Doximity, Inc. (DOCS) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith - FinancialContent
DOCS DEADLINE: Levi & Korsinsky Reminds Doximity, Inc. Investors of Upcoming Securities Class Action Deadline - GlobeNewswire
Important Notice to Long-Term Shareholders of Doximity, - GlobeNewswire
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit - PR Newswire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionDOCS - TMX Newsfile
Deadline Soon: Doximity, Inc. (DOCS) Shareholders Who Lost Money - The National Law Review
Doximity, Inc. (DOCS) stock price, news, quote and history - Yahoo Finance UK
Did You Lose Money on Doximity, Inc. (DOCS)? Levi & Korsinsky Urges Investors to Act Before November 16, 2026 - ACCESS Newswire
DOCS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Doximity, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Doximity, Inc. (DOCS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Doximity, Inc. (DOCS) LawsuitInvestors Urged to Contact Levi & Korsinsky Before November 16, 2026 - ACCESS Newswire
Securities Class Action Lawsuit Filed Against Doximity, Inc. (DOCS)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
Kaplan Fox Encourages Investors of Doximity, Inc. (NYSE: DOCS) to - The National Law Review
Investors Urged to Contact Levi & Korsinsky for Information Before November 16, 2026Doximity, Inc. (DOCS) - ACCESS Newswire
Kaplan Fox Encourages Investors of Doximity, Inc. (NYSE: DOCS) to Contact the Firm Before Lead Plaintiff Deadline on November 16, 2026 - barchart.com
Lost Money on Doximity, Inc. (DOCS)? Urged to Join Class Action Before November 16, 2026Contact Levi & Korsinsky - ACCESS Newswire
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionDOCS - TMX Newsfile
Class Action Filed Against Doximity, Inc. (DOCS) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming DeadlinesDOCS - PR Newswire
DOCS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Doximity, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Lost Money on Doximity, Inc. (DOCS)? Contact Levi & Korsinsky to Join Class Action Before November 16, 2026 - ACCESS Newswire
Class Action Lawsuit Filed: Doximity, Inc. (DOCS)Join by November 16, 2026Contact Levi & Korsinsky - ACCESS Newswire
DOCS Shareholder Alert: Doximity, Inc. Securities Class Action LawsuitInvestors With Losses May Contact SueWallSt - PR Newswire
Can Doximity Keep Shrinking Its Share Count Through Its AI Investment Year? - Trefis
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Finanzdaten der Doximity Inc-Aktie (DOCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.13%
0.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):